| Primary side effect | Secondary side effect | ||||||||||
| Author | n patients (Pat.) | Erythema | Ecchymosis | Hematoma | Edema | Pruritus | Pain | Papule | Nodule | Granuloma | Hyperpigmentation, Depigmentation |
| Fabi, Goldman 2012 [20] | n = 90 | 10% | 17% | 19% | 7% | ||||||
| Narins et al. 2010 [21] | n = 116 | 2.6% | 0.9% | 5.2% | 8.6% | 6.9% | |||||
| Vleggar 2006 [14] | Not specified | 11% | 1.2% | 3.2% | 0.14% | ||||||
| Palm et al. 2010 [22] | n = 130 | 41% | 23% | 8.5% | 0.7% | ||||||
| Lowe et al. 2009 [23] | n = 221 | 39% | 23% | 20% | |||||||
| Schierle, Casas 2011 [24] | n = 106 | 4.7% | |||||||||
| Zielke et al. 2008 [28] | n = 13 | 5.9% | 9.8% | 25% | 9.8% | 66.7% | 17% | ||||
| Woerle 2004 [16] | n = 300 | 10%* 1%** | |||||||||